本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ascendis Pharma A/S

175.40
+0.65000.37%
盘后175.400.00000.00%16:56 EDT
成交量:42.64万
成交额:7,419.87万
市值:106.21亿
市盈率:-27.87
高:176.23
开:175.00
低:171.10
收:174.75
数据加载中...
2019/03/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/12

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/03/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/12

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/02/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/11

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/01/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]